GGrantIndex
Sort

46,585 grants matching heart failure

Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity

$522,926
Steven William Hetts · University Of California, San Francisco · R01 · FY2016 · CA

MK2 Inhibitory Nanoplexes to Enhance Long-Term Vascular Graft Patency

$522,841
Craig Lewis Duvall · Vanderbilt University · R01 · FY2017 · HL

Interplay between mitophagy and substrate utilization in heart failure progression

$522,831
Nuo Sun · Ohio State University · R01 · FY2024 · HL

Pediatric Implantable Artificial Lung

$522,820
Ronald Bruce Hirschl · University Of Michigan At Ann Arbor · R01 · FY2015 · HD

New mechanisms behind skeletal muscle endurance

$522,714
Douglas M Swank · Rensselaer Polytechnic Institute · R01 · FY2025 · AR

Integrating Generative AI with Biomechanics Modeling to Advance Ventricular Disease Diagnosis and Personalized Treatment

$522,695
Lei Shi · Kennesaw State University · R15 · FY2025 · HL

Calcineurin compartmentation and regulation of pathological cardiac remodeling

$522,649
Michael S Kapiloff · Stanford University · R01 · FY2022 · HL

CHEMOREFLEX FUNCTION IN HEART FAILURE

$522,598
Harold D Schultz · University Of Nebraska Medical Center · P01 · FY2008 · HL

Regulation and Function of Cyclic Nucleotide Phosphodiesterase in Cardiac Biology and Disease

$522,565
Chen Yan · University Of Rochester · R01 · FY2022 · HL

Regulation and Function of Cyclic Nucleotide Phosphodiesterase in Cardiac Biology and Disease

$522,565
Chen Yan · University Of Rochester · R01 · FY2021 · HL

Regulation and Function of Cyclic Nucleotide Phosphodiesterase in Cardiac Biology and Disease

$522,565
Chen Yan · University Of Rochester · R01 · FY2023 · HL

Extracellular Matrix Dynamics During Remodeling

$522,494
Steven P. Jones · University Of Louisville · R01 · FY2025 · HL

A system approach to the analysis of Heterotaxy Candiate Genes

$522,463
Mustafa K Khokha · Yale University · R01 · FY2016 · HD

High cGMP Alters Signal Transduction in Cardiac Failure

$522,417
Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2003 · HL

Treatment of Subarachnoid Hemorrhage with Human Albumin

$522,374
Jose I Suarez · Case Western Reserve University · R01 · FY2006 · NS

L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystinuria

$522,334
Amrik Sahota · Rutgers, The State Univ Of N.J. · R01 · FY2021 · DK

Educational strategies to promote post-extubation non-invasive ventilation in patients with acute respiratory failure

$522,309
Timothy D Girard · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · HL

Examining the Effects of High Protein Diet on Outcomes in Heart Failure Patients

$522,191
Lorraine S Evangelista · University Of California Los Angeles · R01 · FY2009 · HL

Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation

$522,000
Jane W. Newburger · Boston Children'S Hospital · U10 · FY2015 · HL

Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation

$522,000
Jane W. Newburger · Boston Children'S Hospital · U10 · FY2013 · HL

Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation

$522,000
Jane W. Newburger · Boston Children'S Hospital · U10 · FY2012 · HL

Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation

$522,000
Jane W. Newburger · Boston Children'S Hospital · U10 · FY2014 · HL

Eliciting Cardiomyocyte Proliferation by Un-blocking Mitotic Transit

$521,946
Lu Han · Medical College Of Wisconsin · R01 · FY2024 · HL

Pre-and Postgraduate Training in Molecular Hematology

$521,878
Stephen Tracy Oh · Washington University · T32 · FY2022 · HL

Role of Diabetes Associated Intestinal Dysbiosis in cardiac disease

$521,855
Jun Zou · Georgia State University · R01 · FY2024 · HL